Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70.

Trial Profile

Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jul 2014

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top